Review paper
Antitumor activity of tipifarnib and PI3K pathway inhibitors in HRAS-associated head and neck squamous cell carcinoma
Abstract
HRAS is an important driver oncogene in head and neck squamous cell carcinoma (HNSCC) and other squamous cell carcinomas. HRAS mutations are found in 4–10% of HNSCC cases and appear to represent a unique subset associated with low TP53 mutation rates, co-mutated caspase 8 and a characteristic methylation pattern. RAS proteins undergo several posttranslational modifications that facilitate their attachment to membranes, including the addition of...
Paper Details
Title
Antitumor activity of tipifarnib and PI3K pathway inhibitors in HRAS-associated head and neck squamous cell carcinoma
Published Date
Oct 1, 2020
Journal
Volume
138
Pages
S43 - S44
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History